That suggests its top-selling insulin products like rapid-acting NovoRapid (insulin aspart), premix NovoMix (insulin aspart/insulin aspart protamine) and long-acting Tresiba (insulin degludec ...

The proposal also advises that the supply of a different insulin medicine, NovoMix 30, is due to end in 2026. Both medicines are supplied by the same company, Novo Nordisk. Heyes says Pharmac ...

That suggests its top-selling insulin products like rapid-acting NovoRapid (insulin aspart), premix NovoMix (insulin aspart/insulin aspart protamine) and long-acting Tresiba (insulin degludec ...